Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 3
Submit an article Journal homepage
2,045
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Zanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final results and correlative analysis of lymphocytosis

Wei Xua Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing, ChinaCorrespondence[email protected]
View further author information
,
Shenmiao Yangb Peking University Peoples Hospital, Peking University Institute of Hematology, Beijing, ChinaView further author information
,
Keshu Zhouc Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, ChinaView further author information
,
Ling Pand West China Hospital of Sichuan University, Chengdu, ChinaView further author information
,
Zengjun Lie Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, ChinaView further author information
,
Sujun Gaof The First Hospital of Jilin University, Changchun, ChinaView further author information
,
Daobin Zhoug Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, ChinaView further author information
,
Jianda Huh Fujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, ChinaView further author information
,
Ru Fengi Nanfang Hospital of Southern Medical University, Guangzhou, ChinaView further author information
,
Haiwen Huangj The First Hospital of Soochow University, Suzhou, ChinaView further author information
,
Tingyu Wange Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, ChinaView further author information
,
Dengju Lik Tongji Hospital, Tongji Medical College, Wuhan, ChinaView further author information
,
Meng Jil BeiGene (Beijing) Co., Ltd., Beijing, China;m BeiGene (Shanghai) Co., Ltd., Shanghai, China;n BeiGene USA, Inc., San Mateo, CA, USAView further author information
,
Haiyi Guol BeiGene (Beijing) Co., Ltd., Beijing, China;m BeiGene (Shanghai) Co., Ltd., Shanghai, China;n BeiGene USA, Inc., San Mateo, CA, USAView further author information
,
Xia Zhaol BeiGene (Beijing) Co., Ltd., Beijing, China;m BeiGene (Shanghai) Co., Ltd., Shanghai, China;n BeiGene USA, Inc., San Mateo, CA, USAORCID Iconhttps://orcid.org/0000-0002-2751-7160View further author information
ORCID Icon,
Binghao Wul BeiGene (Beijing) Co., Ltd., Beijing, China;m BeiGene (Shanghai) Co., Ltd., Shanghai, China;n BeiGene USA, Inc., San Mateo, CA, USAView further author information
,
Yiling Yul BeiGene (Beijing) Co., Ltd., Beijing, China;m BeiGene (Shanghai) Co., Ltd., Shanghai, China;n BeiGene USA, Inc., San Mateo, CA, USAView further author information
,
Yu Wangl BeiGene (Beijing) Co., Ltd., Beijing, China;m BeiGene (Shanghai) Co., Ltd., Shanghai, China;n BeiGene USA, Inc., San Mateo, CA, USAView further author information
,
Jane Huangl BeiGene (Beijing) Co., Ltd., Beijing, China;m BeiGene (Shanghai) Co., Ltd., Shanghai, China;n BeiGene USA, Inc., San Mateo, CA, USAView further author information
,
William Novotnyl BeiGene (Beijing) Co., Ltd., Beijing, China;m BeiGene (Shanghai) Co., Ltd., Shanghai, China;n BeiGene USA, Inc., San Mateo, CA, USAView further author information
&
Jianyong Lia Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 712-716 | Received 24 Jun 2022, Accepted 29 Dec 2022, Published online: 17 Feb 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.